CY1110971T1 - Τοπικη αντιβιοτικη συνθεση για την προληψη της νοσου lyme - Google Patents

Τοπικη αντιβιοτικη συνθεση για την προληψη της νοσου lyme

Info

Publication number
CY1110971T1
CY1110971T1 CY20101101077T CY101101077T CY1110971T1 CY 1110971 T1 CY1110971 T1 CY 1110971T1 CY 20101101077 T CY20101101077 T CY 20101101077T CY 101101077 T CY101101077 T CY 101101077T CY 1110971 T1 CY1110971 T1 CY 1110971T1
Authority
CY
Cyprus
Prior art keywords
antibiotic composition
local antibiotic
prevent lyme
lyme
prevent
Prior art date
Application number
CY20101101077T
Other languages
English (en)
Inventor
Gustave Huber
Uta Hüttenes
Bidder Caroline Roosens-Von
Original Assignee
Ixodes Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ixodes Gmbh filed Critical Ixodes Gmbh
Publication of CY1110971T1 publication Critical patent/CY1110971T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Μια τοπική φαρμακευτική σύνθεση η οποία περιλαμβάνει ένα αντιβιοτικό είναι χρήσιμη για την πρόληψη της νόσου Lyme.
CY20101101077T 2007-07-25 2010-11-25 Τοπικη αντιβιοτικη συνθεση για την προληψη της νοσου lyme CY1110971T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113143 2007-07-25
EP08786388A EP2079441B1 (en) 2007-07-25 2008-07-24 Topical antibiotic composition for the prevention of lyme disease

Publications (1)

Publication Number Publication Date
CY1110971T1 true CY1110971T1 (el) 2015-06-11

Family

ID=39149162

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101101077T CY1110971T1 (el) 2007-07-25 2010-11-25 Τοπικη αντιβιοτικη συνθεση για την προληψη της νοσου lyme

Country Status (15)

Country Link
US (2) US8710019B2 (el)
EP (1) EP2079441B1 (el)
JP (1) JP2010534221A (el)
AT (1) ATE481964T1 (el)
AU (1) AU2008280131B9 (el)
CA (1) CA2694403C (el)
CY (1) CY1110971T1 (el)
DE (1) DE602008002692D1 (el)
DK (1) DK2079441T3 (el)
ES (1) ES2349906T3 (el)
HR (1) HRP20100699T1 (el)
PL (1) PL2079441T3 (el)
PT (1) PT2079441E (el)
SI (1) SI2079441T1 (el)
WO (1) WO2009013331A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
CN107148480A (zh) * 2014-05-09 2017-09-08 张颖 对伯氏疏螺旋体的新型抗病毒活性的鉴定
CA2988575C (en) * 2015-06-10 2024-04-16 Piedmont Animal Health, Llc Injectable antibiotic formulations and use thereof
EP3252470B1 (en) * 2016-06-03 2020-07-29 Te?ted Oy A method and a solid support for detecting tick-borne microbes in a biological sample

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748399C2 (de) * 1976-11-01 1983-09-15 The Procter & Gamble Co., 45202 Cincinnati, Ohio Antimikrobielles Mittel zur örtlichen Anwendung
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
WO1998043673A1 (en) * 1997-03-31 1998-10-08 Johnson & Johnson Consumer Companies, Inc. Solvent system for enhanced penetration of pharmaceutical compounds
US7179475B1 (en) * 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6914051B1 (en) * 2000-06-28 2005-07-05 David M Allen Penetrating antibiotic gel for soft tissue diseases
US6589568B2 (en) * 2001-02-16 2003-07-08 Nurad, Inc. Therapeutic body lotion containing alkali metal hypohalite
NZ532074A (en) * 2001-11-06 2006-02-24 Maxim Pharm Inc Compositions for the treatment of infectious diseases
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

Also Published As

Publication number Publication date
WO2009013331A1 (en) 2009-01-29
JP2010534221A (ja) 2010-11-04
AU2008280131B9 (en) 2014-11-13
US20100130437A1 (en) 2010-05-27
EP2079441B1 (en) 2010-09-22
US8710019B2 (en) 2014-04-29
HRP20100699T1 (hr) 2011-01-31
SI2079441T1 (sl) 2010-12-31
AU2008280131A8 (en) 2010-03-04
EP2079441A1 (en) 2009-07-22
ES2349906T3 (es) 2011-01-12
US9610244B2 (en) 2017-04-04
AU2008280131A1 (en) 2009-01-29
DE602008002692D1 (de) 2010-11-04
CA2694403C (en) 2013-09-24
ATE481964T1 (de) 2010-10-15
PL2079441T3 (pl) 2011-02-28
DK2079441T3 (da) 2010-12-13
CA2694403A1 (en) 2009-01-29
US20140194375A1 (en) 2014-07-10
AU2008280131B2 (en) 2014-06-26
PT2079441E (pt) 2010-11-19

Similar Documents

Publication Publication Date Title
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
GT200600520A (es) Agentes antibacterianos
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
BRPI0922220B8 (pt) uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos
UA107783C2 (en) Isoindoline compounds for use in treating cancer
EA200901617A1 (ru) Борсодержащие молекулы небольшого размера
ATE433980T1 (de) Gyraseinhibitoren und deren verwendungen
EA200970542A1 (ru) ИНГИБИТОРЫ ДЕЙСТВИЯ Akt
BR112012011485A2 (pt) "composições e métodos para tratar náusea e vômito centralmente mediados".
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
NO20081628L (no) Benzodiazepiner som HCV-inhibitorer
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
ATE531721T1 (de) Cyanoaminochinolone als gsk-3-inhibitoren
ATE522500T1 (de) Amidderivate als ionenkanalliganden sowie pharmazeutische zusammensetzungen und verwendungsverfahren dafür
CY1110971T1 (el) Τοπικη αντιβιοτικη συνθεση για την προληψη της νοσου lyme
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
WO2013166282A3 (en) Methods and compositions for treating bacterial infection
EP4137511A4 (en) NEW COMPOSITION FOR USE IN THE TREATMENT AND PREVENTION OF INFECTIONS BY COVID19 AND OTHER CORONAVIRUS
HK1137947A1 (en) Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria
EA200901059A1 (ru) Макролиды на основе эритромицина
WO2012061767A3 (en) Defensin-like molecules as novel antimicrobial agents
EA201270547A1 (ru) Фармацевтическая композиция
WO2009061491A3 (en) Type iii secretion inhibitors and uses thereof
NO20083898L (no) Amid-derivativer som ionekanalligander og farmasoytiske sammensetninger og fremgangsmater for bruk derav